title: Characterization of neutralizing anti-pre-S1 and anti-pre-S2 (HBV) monoclonal antibodies and their fragments.
abstract: Single-chain Fv fragments (scFv) were generated from two murine monoclonal antibodies directed to the neutralizing epitopes of the pre-S1 and pre-S2 region of hepatitis B virus, respectively, using different assembly cloning strategies. The scFv fragments were solubly expressed in E. coli. Dissociation constants were in the nanomolar range for all forms (whole IgG antibodies, Fab fragment and scFv fragments). The epitopes of both antibodies were mapped using solid phase peptide synthesis on continuous cellulose membranes and turned out to be linear determinants. The minimal epitope for the anti-pre-S2 antibody 1F6 was identified to be DPRVRGLYF (amino acid 133-141 of the pre-S region). For the anti-pre-S1 antibody MA 18/7 the minimal epitope proved to be the hexamer LDPAFR (amino acid 30-35 of the pre-S region). Complete substitutional analyses as well as truncation experiments revealed key residues for these antibody-antigen interactions. On the basis of those results we used computer-assisted modeling techniques to suggest models for both antibody-peptide interactions providing insight into the structural basis of these molecular recognitions.
authors.affiliation: Institut für Biochemie, Universitätsklinikum Charité, Humboldt-Universität zu Berlin, Germany. kuettner@charite.de
authors.forename: G
authors.initials: G
authors.lastname: Küttner
authors.forename: A
authors.initials: A
authors.lastname: Kramer
authors.forename: G
authors.initials: G
authors.lastname: Schmidtke
authors.forename: E
authors.initials: E
authors.lastname: Giessmann
authors.forename: L
authors.initials: L
authors.lastname: Dong
authors.forename: D
authors.initials: D
authors.lastname: Roggenbuck
authors.forename: C
authors.initials: C
authors.lastname: Scholz
authors.forename: M
authors.initials: M
authors.lastname: Seifert
authors.forename: R D
authors.initials: RD
authors.lastname: Stigler
authors.forename: J
authors.initials: J
authors.lastname: Schneider-Mergener
authors.forename: T
authors.initials: T
authors.lastname: Porstmann
authors.forename: W
authors.initials: W
authors.lastname: Höhne
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D000911:Antibodies, Monoclonal / Q000737:chemistry / Q000276:immunology*; D001483:Base Sequence; D004247:DNA; D018985:Epitopes, B-Lymphocyte / Q000276:immunology; D015870:Gene Expression; D006510:Hepatitis B Antibodies / Q000737:chemistry / Q000276:immunology*; D006514:Hepatitis B Surface Antigens / Q000276:immunology*; D006801:Humans; D007128:Immunoglobulin Fragments / Q000737:chemistry / Q000276:immunology*; D051379:Mice; D008969:Molecular Sequence Data; D009500:Neutralization Tests; D010455:Peptides / Q000276:immunology; D011498:Protein Precursors / Q000276:immunology*
chemical_list: D000911:Antibodies, Monoclonal; D018985:Epitopes, B-Lymphocyte; D006510:Hepatitis B Antibodies; D006514:Hepatitis B Surface Antigens; D007128:Immunoglobulin Fragments; D010455:Peptides; D011498:Protein Precursors; C055966:immunoglobulin Fv; C050806:presurface protein 1, hepatitis B surface antigen; C050807:presurface protein 2, hepatitis B surface antigen; D004247:DNA